Neopterin in cerebrospinal fluid has also been suggested as a possible biomarker for flu-associated encephalopathy in children.
Function[edit | edit source]
Research on brains affected by Alzheimer's disease has shown levels of neopterin are five times higher than in healthy brains. Some evidence suggests that microglia may produce neopterin during physiological stress, and that neopterin may have a protective role in response to damage or inflammation.
ME/CFS[edit | edit source]
Notable studies[edit | edit source]
- 2012, Evidence for inflammation and activation of cell-mediated immunity in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): increased interleukin-1, tumor necrosis factor-α, PMN-elastase, lysozyme and neopterin. - (Abstract)
- 2021, The Reification of the Clinical Diagnosis of Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME/CFS) as an Immune and Oxidative Stress Disorder: Construction of a Data-Driven Nomothethic Network and Exposure of ME/CFS Subgroups - (Full text)
See also[edit | edit source]
Learn more[edit | edit source]
References[edit | edit source]
- Verheul, Cassandra; Kleijn, Anne; Lamfers, Martine L. M. (January 1, 2018). Deisenhammer, Florian; Teunissen, Charlotte E.; Tumani, Hayrettin (eds.). Chapter 10 - Cerebrospinal fluid biomarkers of malignancies located in the central nervous system. Cerebrospinal Fluid in Neurologic Disorders. 146. Elsevier. pp. 139–169.
- Colette Daubner, S.; Lanzas, Ronald O. (January 1, 2018). Pteridines☆. Elsevier. ISBN 978-0-12-801238-3.
- Rovenský, Jozef; Payer, Juraj; Herold, Manfred (November 16, 2015). Dictionary of Rheumatology. Springer. ISBN 978-3-319-21335-4.
- Macdonald-Laurs, Emma; Koirala, Archana; Britton, Philip N.; Rawlinson, William; Hiew, Chee Chung; Mcrae, Jocelynne; Dale, Russell C.; Jones, Cheryl; Macartney, Kristine (January 1, 2019). "CSF neopterin, a useful biomarker in children presenting with influenza associated encephalopathy?". European Journal of Paediatric Neurology. 23 (1): 204–213. doi:10.1016/j.ejpn.2018.09.009. ISSN 1090-3798.
- Maes, Michael; Twisk, Frank N.M.; Kubera, Marta; Ringel, Karl (February 2012). "Evidence for inflammation and activation of cell-mediated immunity in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): Increased interleukin-1, tumor necrosis factor-α, PMN-elastase, lysozyme and neopterin". Journal of Affective Disorders. 136 (3): 933–939. doi:10.1016/j.jad.2011.09.004. ISSN 0165-0327.
- Maes, Michael; Kubera, Marta; Stoyanova, Kristina; Leunis, Jean-Claude (January 29, 2021). "The Reification of the Clinical Diagnosis of Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME/CFS) as an Immune and Oxidative Stress Disorder: Construction of a Data-Driven Nomothethic Network and Exposure of ME/CFS Subgroups". Preprints. doi:10.20944/preprints202101.0623.v1. Retrieved February 12, 2021.
metabolite A chemical compound produced by, or involved in, metabolism. The term is often used to refer to the degradation products of drugs in the body.
myalgic encephalomyelitis (ME) - A disease often marked by neurological symptoms, but fatigue is sometimes a symptom as well. Some diagnostic criteria distinguish it from chronic fatigue syndrome, while other diagnostic criteria consider it to be a synonym for chronic fatigue syndrome. A defining characteristic of ME is post-exertional malaise (PEM), or post-exertional neuroimmune exhaustion (PENE), which is a notable exacerbation of symptoms brought on by small exertions. PEM can last for days or weeks. Symptoms can include cognitive impairments, muscle pain (myalgia), trouble remaining upright (orthostatic intolerance), sleep abnormalities, and gastro-intestinal impairments, among others. An estimated 25% of those suffering from ME are housebound or bedbound. The World Health Organization (WHO) classifies ME as a neurological disease.
γ γ / Γ. Greek letter gamma/gamme (symbol), third letter of the Greek alphabet.